GenericsWeb Market Research Reports

Home
GenericsWeb

GenericsWeb Market Research Reports

GenericsWeb provides patent intelligence to the world’s leading pharmaceutical companies, allowing their customers to significantly reduce the risk of developing patent-infringing pharmaceuticals for global markets, and identify when and where they can launch products. With headquarters in Sydney, and customer support offices in North America and Europe, GenericsWeb boasts 50% of the world’s top 10 generics companies as key customers, including global heavyweights such as Pfizer, Novartis/Sandoz, Hospira, Mylan, Sanofi-Aventis, Dr Reddy’s, Amgen and Baxter

List of reports from GenericsWeb

Displaying 1 to 30 (of 731 records)

Pages: « Last 1 2 3 4 5 6 7 8 9 10 Next »

Nilotinib - Key patent, SPC, and data exclusivity expiry (44 country coverage) Jun 2013 Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Nilotinib Nilotinib indications: Treatment of...	$1200
Avibactam - Key patent, SPC, and data exclusivity expiry (44 country coverage) Jun 2013 Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Avibactam Avibactam indications: Treatment of Gram-negative...	$1200
Ceftolozane - Key patent, SPC, and data exclusivity expiry (44 country coverage) Jun 2013 Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Ceftolozane Ceftolozane indications: Treatment of...	$1200
Ceftobiprole - Key patent, SPC, and data exclusivity expiry (44 country coverage) Jun 2013 Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Ceftobiprole Ceftobiprole indications: Treatment for...	$1200
Deferasirox - Key patent, SPC, and data exclusivity expiry (44 country coverage) Jun 2013 Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Deferasirox Deferasirox indications: Treatment of chronic...	$1200
Nilotinib - Comprehensive patent search Jun 2013 Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched...	$7200
Avibactam - Comprehensive patent search Jun 2013 Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched...	$7200
Ceftolozane - Comprehensive patent search Jun 2013 Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched...	$7200
Ceftobiprole - Comprehensive patent search Jun 2013 Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched...	$7200
Deferasirox - Comprehensive patent search Jun 2013 Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched...	$5600
Amorolfine - Key patent, SPC, and data exclusivity expiry (44 country coverage) May 2013 Amorolfine - Key patent, SPC, and data exclusivity expiry (44 countries coverage) Pipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players....	$1200
Doripenem - Key patent, SPC, and data exclusivity expiry (44 country coverage) May 2013 Doripenem - Key patent, SPC, and data exclusivity expiry (44 countries coverage) Pipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This...	$1200
Fosamprenaivr - Comprehensive patent search May 2013 Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly...	$7200
Suvorexant - Comprehensive patent search Apr 2013 Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and...	$5600
Insulin Aspart - Comprehensive patent search Apr 2013 Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and...	$10500
Clindamycin - Key patent, SPC, and data exclusivity expiry (44 country coverage) Feb 2013 Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Clindamycin Clindamycin indications: Treatment of...	$1200
Ceftriaxone - Key patent, SPC, and data exclusivity expiry (44 country coverage) Feb 2013 Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Ceftriaxone Ceftriaxone indications: Treatment of...	$1200
Cefazolin - Key patent, SPC, and data exclusivity expiry (44 country coverage) Feb 2013 Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Cefazolin Cefazolin indications: Treatment of...	$1200
Bendamustine - Key patent, SPC, and data exclusivity expiry (44 country coverage) Feb 2013 Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Bendamustine Bendamustine indications: Treatment of...	$1200
Dexmedetomidine - Key patent, SPC, and data exclusivity expiry (44 country coverage) Feb 2013 Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Dexmedetomidine Dexmedetomidine indications:...	$1200
Axitinib - Key patent, SPC, and data exclusivity expiry (44 country coverage) Feb 2013 Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Axitinib Axitinib indications: Treatment of...	$1200
Canagliflozin - Key patent, SPC, and data exclusivity expiry (44 country coverage) Feb 2013 Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Canagliflozin Canagliflozin indications: Treatment...	$1200
Dapagliflozin - Key patent, SPC, and data exclusivity expiry (44 country coverage) Feb 2013 Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Dapagliflozin Dapagliflozin indications: Adjunctive...	$1200
Vemurafenib - Key patent, SPC, and data exclusivity expiry (44 country coverage) Nov 2012 Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Vemurafenib Vemurafenib indications:...	$1200
Colesevelam - Key patent, SPC, and data exclusivity expiry (44 country coverage) Nov 2012 Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Colesevelam Colesevelam indications:...	$1200
Rifaximin - Key patent, SPC, and data exclusivity expiry (44 country coverage) Nov 2012 Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Rifaximin Rifaximin indications: Treatment of...	$1200
Nevirapine - Key patent, SPC, and data exclusivity expiry (44 country coverage) Nov 2012 Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Nevirapine Nevirapine indications: Treatment...	$1200
Liraglutide - Key patent, SPC, and data exclusivity expiry (44 country coverage) Nov 2012 Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Liraglutide Liraglutide indications: Treatment of...	$1200
Vilazodone - Key patent, SPC, and data exclusivity expiry (44 country coverage) Nov 2012 Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Vilazodone Vilazodone indications: Treatment of...	$1200
Hexylaminolevulinic Acid - Key patent, SPC, and data exclusivity expiry (44 country coverage) Nov 2012 Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Hexylaminolevulinic Acid Hexylaminolevulinic Acid...	$1200

Displaying 1 to 30 (of 731 records)

Pages: « Last 1 2 3 4 5 6 7 8 9 10 Next »

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)

Tel: +1-518-618-1030
Email: sales@researchmoz.com

Main Category

Popular Reports

Popular Publishers

View All